Funding for this research was provided by:
Sysmex Europe SE
Received: 28 June 2022
Accepted: 5 October 2022
First Online: 25 October 2022
: Study approval (protocol number #19/09/2396) was granted by the National Health Sciences Research Committee of the Malawi Ministry of Health. Donor informed consent was waived as there was no additional blood draw and consent to donate includes consent to use donated blood samples and biodata for research to improve blood safety and/or in studies of public health importance. Donors are informed that they can withdraw their consent for the use of their donated blood samples for research purposes, inherent in the general consent to donate blood, at any time pre- or post-donation.
: Not applicable.
: TH, MM and JS are full-time employees of Sysmex Europe SE who funded the study. TLC provides consultancy services to Sysmex Europe SE. The other authors have no competing interests to declare.